Schonfeld Strategic Advisors’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-18,100
Closed -$131K 1634
2020
Q1
$131K Buy
18,100
+900
+5% +$6.67K 0.01% 975
2019
Q4
$152K Buy
+17,200
New +$129K ﹤0.01% 1194
2019
Q1
Sell
-16,211
Closed -$105K 1371
2018
Q4
$105K Buy
+16,211
New +$124K ﹤0.01% 1005
2017
Q1
Sell
-108,461
Closed -$1.17M 780
2016
Q4
$1.17M Sell
108,461
-11,566
-10% -$154K 0.15% 207
2016
Q3
$1.96M Buy
120,027
+49,473
+70% +$696K 0.33% 77
2016
Q2
$672K Buy
+70,554
New +$768K 0.15% 185

Other funds holding NPTN

Schonfeld Strategic Advisors's NPTN Position: Q2 2020 in Review

Schonfeld Strategic Advisors sold out of NEOPHOTONICS CORP (NPTN) in Q2 2020, closing a stake of 18,100 shares — an estimated $131K sold.

Schonfeld Strategic Advisors first reported a position in NPTN in Q2 2016 and held it in 6 quarters. The position peaked at $1.96M in Q3 2016. 163 funds tracked by Wall St. Rank hold NPTN as of Q2 2020.

  • Schonfeld Strategic Advisors reported no remaining NEOPHOTONICS CORP position as of Q2 2020 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 18,100 NEOPHOTONICS CORP shares in Q2 2020, an estimated $131K.
  • Schonfeld Strategic Advisors first reported a position in NEOPHOTONICS CORP in Q2 2016 and held it in 6 quarters.
  • Schonfeld Strategic Advisors's NEOPHOTONICS CORP position peaked at $1.96M in Q3 2016.
  • 163 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2020.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.